Table 5.
Predictors of IHM and MACCE in NSTEMI and STEMI patients with cardiogenic shock
| Overall cohort (+) CS | NSTEMI (+) CS | STEMI (+) CS | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
| In‐hospital Mortality | |||||||||
| Smoker | 3.06 | 1.12–8.33 | 0.029 | ||||||
| Prior MI | 2.90 | 1.37–6.15 | 0.005 | ||||||
| LVEF | 0.98 | 0.96–1.00 | 0.038 | 0.97 | 0.93–1.00 | 0.033 | |||
| Logistic EuroSCORE | 1.04 | 1.03–1.06 | <0.001 | 1.06 | 1.03–1.08 | <0.001 | |||
| CPB time (min) | 1.03 | 1.02–1.04 | <0.001 | 1.03 | 1.02–1.05 | <0.001 | 1.03 | 1.02–1.04 | <0.001 |
| Aortic clamp time (min) | 0.96 | 0.95–0.98 | <0.001 | 0.97 | 0.94–0.99 | 0.003 | 0.96 | 0.94–0.98 | <0.001 |
| MACCE | |||||||||
| Diabetes mellitus | 3.13 | 1.29–7.61 | 0.012 | ||||||
| Peripheral vascular disease | 4.11 | 1.56–10.84 | 0.004 | 3.54 | 1.11–11.25 | 0.032 | 7.02 | 1.75–28.19 | 0.006 |
| CKD‐EPI Stage 3–4 | 2.06 | 1.14–3.71 | 0.016 | 2.93 | 1.37–6.28 | 0.006 | |||
| Prior MI | 4.21 | 1.51–11.73 | 0.006 | ||||||
| Prior stroke | 2.93 | 1.08–7.93 | 0.035 | ||||||
| LVEF | 0.97 | 0.95–0.98 | <0.001 | 0.96 | 0.93–0.98 | 0.001 | |||
| Troponin >2x ULN | 4.66 | 1.27–17.17 | 0.021 | ||||||
| CPB time (min) | 1.02 | 1.01–1.03 | <0.001 | 1.03 | 1.01–1.04 | <0.001 | 1.03 | 1.01–1.04 | <0.001 |
| Aortic clamp time (min) | 0.97 | 0.96–0.99 | 0.001 | 0.97 | 0.95–0.99 | 0.001 | 0.97 | 0.95–0.99 | 0.001 |
| Warm vs cold blood CP | 2.29 | 1.27–4.15 | 0.006 | 1.17 | 0.55–2.50 | 0.008 | |||
CKD‐EPI indicates Chronic Kidney Disease Epidemiology Collaboration; CP, cardioplegia; CPB, cardiopulmonary bypass; EuroSCORE, European System for Cardiac Operative Risk Evaluation; IHM, in‐hospital mortality; LVEF, left ventricular ejection fraction; MACCE, major adverse cardiocerebral events; MI, myocardial infarction; NSTEMI, non–ST‐segment–elevation myocardial infarction; OR, odds ratio; STEMI, ST‐segment–elevation myocardial infarction; ULN, upper limit of normal.